Equibles does not estimate personal net worth.
Get an email with a short summary when Becton Dickinson & Co publishes a filing, an earnings call transcript or a press release.
Get BDX alertsTom Polen is recorded as CEO at Becton Dickinson & Co (BDX). Tom Polen has spoken on 18 earnings calls and 1 other investor event across 1 company, most recently for Becton Dickinson & Co on August 6, 2026. Becton Dickinson & Co is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Becton Dickinson & Co includes David F. Melcher (Chairman), Thomas E. Polen (Chairman and Board Member), Patrick K. Kaltenbach (CTO) and 7 others.
“We delivered a strong third quarter with revenue, adjusted operating margin, and adjusted EPS all ahead of our expectations.”
“But the good news is that, of course, those elements, they're becoming a larger portion of the company. And just given their scale, each of those are now scaled. like Biologics is over a billion-dollar business.”
“Before turning to Q2 results, I wanted to take a moment to highlight this morning our announcement of Vitor Roque as CFO. As you know, Vitor has been interim CFO since last fall and has done a fantastic job serving as a partner to me and the leadership team.”
“We have a number of significant updates to share on how we are creating value through our BD 2025 strategy.”
“First, I'd like to take a moment to welcome Mike Feld, President of our Life Science segment, who joined BD in August from Veralto. Mike is known for building innovative, high-performing teams, and his leadership principles are well aligned with BD's culture.”
Medical Instruments & Supplies · Healthcare
CEO
